Showing results (351-360 of 609) with videos related to
Sort By:
Pageof 61
BJU International|January 20, 2012
Novel approaches to improve prostate cancer diagnosis and management in early-stage diseaseMichael Marberger, Jelle Barentsz, Mark Emberton, et al.The Journal of Urology|February 23, 2010
[-2]Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening studyBrian V Le, Christopher R Griffin, Stacy Loeb, et al.The Journal of Urology|October 12, 2005
Obesity and capsular incision at the time of open retropubic radical prostatectomyStephen J Freedland, Kelly A Grubb, Sindy K Yiu, et al.BJU International|November 4, 2010
Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matchingAhmed Magheli, Mark L Gonzalgo, Li-Ming Su, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2005
Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomyPatrick J Bastian, Ganesh S Palapattu, Xiaohui Lin, et al.European Urology|December 7, 2007
Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomyMichael Müntener, Jonathan I Epstein, David J Hernandez, et al.Journal of Endourology|April 19, 2008
Thoracic complications of urologic laparoscopy: correlation between radiographic findings and clinical manifestationsLee C Zhao, Justin S Han, Stacy Loeb, et al.BJU International|May 12, 2015
Population-based study of long-term functional outcomes after prostate cancer treatmentSigrid Carlsson, Linda Drevin, Stacy Loeb, et al.The Journal of Urology|November 16, 2007
The natural history of men treated with deferred androgen deprivation therapy in whom metastatic prostate cancer developed following radical prostatectomyDanil V Makarov, Elizabeth B Humphreys, Leslie A Mangold, et al.BJU International|October 14, 2011
Clinical evaluation of a novel method for the measurement of prostate-specific antigen, AccuPSA(TM) , as a predictor of 5-year biochemical recurrence-free survival after radical prostatectomy: results of a pilot studyHerbert Lepor, Carol D Cheli, Robert P Thiel, et al.Pageof 61